Precipio Inc (NASDAQ:PRPO)’s share price fell 0.6% on Monday . The stock traded as low as $0.16 and last traded at $0.16. 700,145 shares were traded during trading, a decline of 78% from the average session volume of 3,117,182 shares. The stock had previously closed at $0.17.
The company has a quick ratio of 0.13, a current ratio of 0.14 and a debt-to-equity ratio of 0.30.
Precipio (NASDAQ:PRPO) last released its quarterly earnings data on Monday, November 19th. The biotechnology company reported ($0.13) EPS for the quarter. The business had revenue of $0.65 million for the quarter. Precipio had a negative net margin of 610.39% and a negative return on equity of 149.24%.
TRADEMARK VIOLATION NOTICE: This report was reported by Highlight Press and is owned by of Highlight Press. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://highlightpress.com/2019/02/11/precipio-prpo-trading-down-0-6.html.
About Precipio (NASDAQ:PRPO)
Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.